740 related articles for article (PubMed ID: 11350666)
1. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
[TBL] [Abstract][Full Text] [Related]
2. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
Resino S; Navarro J; Bellón JM; Gurbindo D; León JA; Muñoz-Fernández MA
Clin Exp Immunol; 2001 Aug; 125(2):266-73. PubMed ID: 11529919
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
[TBL] [Abstract][Full Text] [Related]
4. [T-cell subsets variation during clinical and immunological progression in vertically HIV-infected children].
Resino García S; Bellón Cano JM; Navarro Caspistegui J; Gurbindo Gutiérrez D; León Leal JA; Muñoz-Fernández MA
Medicina (B Aires); 2001; 61(5 Pt 1):557-65. PubMed ID: 11721322
[TBL] [Abstract][Full Text] [Related]
5. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
Paul ME; Shearer WT; Kozinetz CA; Lewis DE
J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
[TBL] [Abstract][Full Text] [Related]
6. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
[TBL] [Abstract][Full Text] [Related]
8. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
Choremi-Papadopoulou H; Tsalimalma K; Dafni U; Dimitracopoulou A; Kordossis T
J Med Virol; 2004 Jun; 73(2):235-43. PubMed ID: 15122798
[TBL] [Abstract][Full Text] [Related]
9. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.
Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
J Immunol; 1999 Sep; 163(6):3539-48. PubMed ID: 10477629
[TBL] [Abstract][Full Text] [Related]
10. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.
Bürgisser P; Hammann C; Kaufmann D; Battegay M; Rutschmann OT
Clin Exp Immunol; 1999 Mar; 115(3):458-63. PubMed ID: 10193418
[TBL] [Abstract][Full Text] [Related]
12. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.
Resino S; Abad ML; Navarro J; Bellón JM; Sánchez-Ramón S; Angeles Muñoz-Fernández M
Clin Exp Immunol; 2003 Jan; 131(1):130-7. PubMed ID: 12519396
[TBL] [Abstract][Full Text] [Related]
13. Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS.
Resino S; Correa R; Bellón JM; Sánchez-Ramón S; Muñoz-Fernández MA
AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1395-406. PubMed ID: 12487811
[TBL] [Abstract][Full Text] [Related]
14. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
[TBL] [Abstract][Full Text] [Related]
15. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
[TBL] [Abstract][Full Text] [Related]
16. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
[TBL] [Abstract][Full Text] [Related]
17. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
Beran O; Holub M; Spála J; Kalanin J; Stanková M
Acta Virol; 2003; 47(2):121-4. PubMed ID: 14524479
[TBL] [Abstract][Full Text] [Related]
18. CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy.
Resino S; Seoane E; Gutiérrez MD; León JA; Muñoz-Fernández MA
J Acquir Immune Defic Syndr; 2006 Jul; 42(3):269-76. PubMed ID: 16810122
[TBL] [Abstract][Full Text] [Related]
19. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
[TBL] [Abstract][Full Text] [Related]
20. Cd4+ T cells programmed to traffic to lymph nodes account for increases in numbers of cd4+ T cells up to 1 year after the initiation of highly active antiretroviral therapy for human immunodeficiency virus type 1 infection.
Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
J Infect Dis; 2001 Jul; 184(1):93-7. PubMed ID: 11398115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
